The Shannon entropy used to measure HSPCs heterogeneity in two independent MFC datasets revealed that CD34 + CD38+HSPCs entropy was significantly decreased in a subset of MDS patients including at early stage of the disease. This evidence concerns the gene CD38 and myelodysplastic syndrome.